PHACE Syndrome: Current Knowledge, Future Directions
Denise W. Metry M.D.
Baylor College of Medicine, Houston, Texas
Search for more papers by this authorBeth A. Drolet M.D.
Medical College of Wisconsin, Milwaukee, Wisconsin
Search for more papers by this authorPeter Frommelt M.D.
Medical College of Wisconsin, Milwaukee, Wisconsin
Search for more papers by this authorJudith Hall M.D.
University of British Columbia, Vancouver, British Colombia
Search for more papers by this authorChristopher P. Hess M.D., Ph.D.
University of California, San Francisco, California
Search for more papers by this authorGeoffrey L. Heyer M.D.
Nationwide Children’s Hospital, Columbus, Ohio
Search for more papers by this authorDawn Siegel M.D.
Oregon Health and Science University, Portland, Oregon
Search for more papers by this authorEulalia Baselga M.D.
Hospital de la Santa Creu I Sant Pau, Barcelona, Spain
Search for more papers by this authorWilliam Katowitz M.D.
Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
Search for more papers by this authorMoise L. Levy M.D.
Dell Children’s Medical Center, Austin, Texas
Search for more papers by this authorAnthony Mancini M.D.
Northwestern University, Chicago, Illinois
Search for more papers by this authorMandi L. Maronn M.D.
Baylor College of Medicine, Houston, Texas
Search for more papers by this authorThuy Phung M.D., PhD.
Baylor College of Medicine, Houston, Texas
Search for more papers by this authorElena Pope M.D.
The Hospital for Sick Children, Toronto, Ontario, Canada
Search for more papers by this authorIlona J. Frieden M.D.
University of California, San Francisco, California
Search for more papers by this authorDenise W. Metry M.D.
Baylor College of Medicine, Houston, Texas
Search for more papers by this authorBeth A. Drolet M.D.
Medical College of Wisconsin, Milwaukee, Wisconsin
Search for more papers by this authorPeter Frommelt M.D.
Medical College of Wisconsin, Milwaukee, Wisconsin
Search for more papers by this authorJudith Hall M.D.
University of British Columbia, Vancouver, British Colombia
Search for more papers by this authorChristopher P. Hess M.D., Ph.D.
University of California, San Francisco, California
Search for more papers by this authorGeoffrey L. Heyer M.D.
Nationwide Children’s Hospital, Columbus, Ohio
Search for more papers by this authorDawn Siegel M.D.
Oregon Health and Science University, Portland, Oregon
Search for more papers by this authorEulalia Baselga M.D.
Hospital de la Santa Creu I Sant Pau, Barcelona, Spain
Search for more papers by this authorWilliam Katowitz M.D.
Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
Search for more papers by this authorMoise L. Levy M.D.
Dell Children’s Medical Center, Austin, Texas
Search for more papers by this authorAnthony Mancini M.D.
Northwestern University, Chicago, Illinois
Search for more papers by this authorMandi L. Maronn M.D.
Baylor College of Medicine, Houston, Texas
Search for more papers by this authorThuy Phung M.D., PhD.
Baylor College of Medicine, Houston, Texas
Search for more papers by this authorElena Pope M.D.
The Hospital for Sick Children, Toronto, Ontario, Canada
Search for more papers by this authorIlona J. Frieden M.D.
University of California, San Francisco, California
Search for more papers by this authorProceedings of a Research Conference November 7–8, 2008 Houston, Texas, USA
Abstract
Abstract: On November 7–8, 2008, physicians gathered in Houston Texas for the first-ever workshop on PHACE syndrome, an important and recently described neurocutaneous syndrome. This article represents a summary of the discussions held at that workshop, which was attended by a broad range of medical specialists.
References
- 1 Kilcline C, Frieden IJ. Infantile hemangiomas: how common are they? A systematic review of the literature Pediatr Dermatol 2008; 25: 168–173.
- 2 Frieden IJ, Reese V, Cohen D. PHACE syndrome: the association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects and eye abnormalities. Arch Dermatol 1996; 132: 307–311.
- 3 Metry DW, Dowd CF, Barkovich J et al. The many faces of PHACE syndrome. J Pediatr 2001; 139: 17–25.
- 4 Burrows PE, Robertson RL, Mulliken JB et al. Cerebral vasculopathy and neurologic sequelae in infants with cervicofacial hemangioma: report of eight patients. Radiology 1998; 207: 601–607.
- 5 Drolet BA, Dohil M, Golomb MR et al. Early stroke and cerebral vasculopathy in children with facial hemangiomas and PHACE association. Pediatrics 2006; 117: 959–964.
- 6 Hess CP, Fullerton HJ, Auguste KI et al. The spectrum of cerebrovascular anomalies in PHACES. 17th International Workshop On Vascular Anomalies, June 21–24, 2008, Boston, MA, USA (Abstract).
- 7 Heyer GL, Dowling MM, Licht DJ et al. The cerebral vasculopathy of PHACES syndrome. Stroke 2008; 39: 308–316.
- 8 Metry DW, Haggstrom AN, Drolet BA et al. A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical findings, and complications. Am J Med Genet A 2006; 140: 975–986.
- 9 Chiller KG, Passaro D, Frieden IJ. Hemangiomas of infancy: clinical characteristics, morphologic subtypes and their relationship to race, ethnicity and sex. Arch Dermatol 2002; 138: 1567–1576.
- 10 Poetke M, Frommeld T, Berlien HP. PHACE syndrome: new views on diagnostic criteria. Eur J Pediatr Surg 2002; 12: 366–374.
- 11 Mulliken JB, Marler JJ, Burrows PE et al. Reticular infantile hemangioma of the limb can be associated with ventral-caudal anomalies, refractory ulceration, and cardiac overload. Pediatr Dermatol 2007; 24: 356–362.
- 12 Metry DW, Siegel DH, Cordisco MR et al. A comparison of disease severity among affected male versus female patients with PHACE syndrome. J Am Acad Dermatol 2008; 58: 81–87.
- 13 Poindexter G, Metry DW, Barkovich AJ et al. PHACE syndrome with intracerebral hemangiomas, heterotopia, and endocrine dysfunction. Pediatr Neurol 2007; 36: 402–406.
- 14 Haggstrom A, Baselga E, Chamlin S et al. Large facial hemangiomas: what is the risk of PHACE? 17th International Workshop on Vascular Anomalies June 21–24, 2008, Boston, MA (Abstract).
- 15 Haggstrom AN, Lammer EJ, Schneider RA et al. Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 2006; 117: 698–703.
- 16 Rao R, Holland K, Drolet B et al. PHACES association: a vasculocutaneous syndrome. Pediatr Cardiol 2008; 29: 793–799.
- 17 Heyer GL, Millar WS, Ghatan S et al. The neurologic aspects of PHACE: case report and review of the literature. Pediatr Neurol 2006; 35: 419–424.
- 18 Oza VS, Wang E, Berenstein A et al. PHACES association: a neuroradiologic review of 17 patients. Am J Neuroradiol 2008; 29: 814–815.
- 19 Komiyama M, Yasui T, Sakamoto H et al. Basal meningoencephalocele, anomaly of optic disc and panhypopituitarism in association with moyamoya disease. Pediatr Neurosurg 2000; 33: 100–104.
- 20 Pierre-Filho Pde T, Limeira-Soares PH, Marcondes AM. Morning glory syndrome associated with posterior pituitary ectopia and hypopituitarism. Acta Ophthalmol Scand 2004; 82: 89–92.
- 21 Traggiai C, Stanhope R. Endocrinopathies associated with midline cerebral and cranial malformations. J Pediatr 2002; 140: 252–255.
- 22 Reese V, Frieden IJ, Paller AS et al. The association of facial hemangiomas with Dandy-Walker and other posterior fossa malformations. J Pediatr 1993; 122: 379–384.
- 23 Szabo S, Drolet BA, Jensen J et al. Early regressive and abnormally persistent infantile hemangiomas (IHs): learning from the extremes. International Society for the Study of Vascular Anomalies 17th International Workshop on Vascular Anomalies, June 23, 2008, Boston MA (Abstract).
- 24 North PE, Waner M, Mizeracki A et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000; 31: 11–22.
- 25 Airley R, Loncaster J, Davidson S et al. Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res 2001; 7: 928–934.
- 26 Kleinman ME, Greives MR, Churgin SS et al. Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma. Arterioscler Thromb Vasc Biol 2007; 27: 2664–2670.
- 27 Metry D, Heyer G, Hess C et al. Consensus statement on diagnostic criteria for PHACE syndrome Pediatrics (in press).
- 28 Leaute-Labreze C, Dumas de la Roque E, Hubiche T et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649–2651.
Citing Literature
